Liver Cancer (Oct 2024)
Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition)
- Yu Yang,
- Juxian Sun,
- Jianqiang Cai,
- Minshan Chen,
- Chaoliu Dai,
- Tianfu Wen,
- Jinglin Xia,
- Mingang Ying,
- Zhiwei Zhang,
- Xuewen Zhang,
- Chihua Fang,
- Feng Shen,
- Ping An,
- Qingxian Cai,
- Jingyu Cao,
- Zhen Zeng,
- Gang Chen,
- Juan Chen,
- Ping Chen,
- Yongshun Chen,
- Yunfeng Shan,
- Shuangsuo Dang,
- Wei-Xing Guo,
- Jiefeng He,
- Heping Hu,
- Bin Huang,
- Weidong Jia,
- Kexiang Jiang,
- Yan Jin,
- Yongdong Jin,
- Yun Jin,
- Gong Li,
- Yun Liang,
- Enyu Liu,
- Hao Liu,
- Wei Peng,
- Zhenwei Peng,
- Zhiyi Peng,
- Yeben Qian,
- Wanhua Ren,
- Jie Shi,
- Yusheng Song,
- Min Tao,
- Jun Tie,
- Xueying Wan,
- Bin Wang,
- Jin Wang,
- Kai Wang,
- Kang Wang,
- Xin Wang,
- Wenjing Wei,
- Fei-Xiang Wu,
- Bangde Xiang,
- Lin Xie,
- Jianming Xu,
- Mao-Lin Yan,
- Yufu Ye,
- Jinbo Yue,
- Xiaoxun Zhang,
- Yu Zhang,
- Aibin Zhang,
- Haitao Zhao,
- Weifeng Zhao,
- Xin Zheng,
- Hongkun Zhou,
- Huabang Zhou,
- Jun Zhou,
- Xinmin Zhou,
- Shu-Qun Cheng,
- Qiu Li
Affiliations
- Yu Yang
- Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China
- Juxian Sun
- Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China
- Jianqiang Cai
- Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Minshan Chen
- Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
- Chaoliu Dai
- Department of Hepatobiliary and Splenic Surgery, Shengjing Hospital Affiliated to China Medical University, Shenyang, China
- Tianfu Wen
- Department of Liver Surgery & Liver Transplantation Centre, West China Hospital of Sichuan University, Chengdu, China
- Jinglin Xia
- Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
- Mingang Ying
- Department of Abdominal Surgery, Fujian Provincial Cancer Hospital, Fujian Medical University Teaching Hospital, Fuzhou, China
- Zhiwei Zhang
- Department of Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- Xuewen Zhang
- Department of Hepatobiliary and Pancreas Surgery, The Second Hospital of Jilin University, Changchun, China
- Chihua Fang
- Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China
- Feng Shen
- Department of Hepatic Surgery IV, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China
- Ping An
- Department of Infectious Diseases, The Sixth People’s Hospital of Shenyang, Shenyang, China
- Qingxian Cai
- National Clinical Research Center for Infectious Diseases, The Third People’s Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China
- Jingyu Cao
- Department of Hepatobiliary Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China
- Zhen Zeng
- Comprehensive Liver Cancer Center, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
- Gang Chen
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
- Juan Chen
- Department of Radiology, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China
- Ping Chen
- Department of Infectious Diseases, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, China
- Yongshun Chen
- Department of Clinical Oncology, Renmin Hospital of Wuhan University, Wuhan, China
- Yunfeng Shan
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
- Shuangsuo Dang
- Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
- Wei-Xing Guo
- Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China
- Jiefeng He
- Department of Hepatobiliary Surgery, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Taiyuan, China
- Heping Hu
- Department of Gastroenterology, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China
- Bin Huang
- Department of Radiology, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China
- Weidong Jia
- Department of General Surgery, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China
- Kexiang Jiang
- Department of Hepatobiliary Surgery, Zhuji People’s Hospital of Zhejiang Province, Zhuji, China
- Yan Jin
- Department of Hepatobiliary and Pancreatic Surgery, First People’s Hospital of Yunnan Province, Affiliated Hospital of KMUST, Kumming, China
- Yongdong Jin
- Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
- Yun Jin
- Department of Hepatobiliary and Pancreatic Surgery, First People’s Hospital of Yunnan Province, Affiliated Hospital of KMUST, Kumming, China
- Gong Li
- Department of Radiation Oncology, Beijing Tsinghua Changgung Hospital, Beijing, China
- Yun Liang
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China
- Enyu Liu
- Department of General Surgery, Qilu Hospital of Shandong University, Jinan, China
- Hao Liu
- Cancer Center, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
- Wei Peng
- Department of Liver Surgery & Liver Transplantation Centre, West China Hospital of Sichuan University, Chengdu, China
- Zhenwei Peng
- Cancer Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
- Zhiyi Peng
- Department of Radiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
- Yeben Qian
- Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China
- Wanhua Ren
- Department of Infectious Diseases, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
- Jie Shi
- Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China
- Yusheng Song
- Department of Interventional Radiology, Ganzhou People’s Hospital, Ganzhou, China
- Min Tao
- Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China
- Jun Tie
- National Clinical Research Center for Digestive Diseases, State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases, Xijing Hospital, Air Force Military Medical University, Xi'an, China
- Xueying Wan
- Department of Chinese Traditional Medicine, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China
- Bin Wang
- Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan, China
- Jin Wang
- Department of Oncology, MianYang Central Hospital, MianYang, China
- Kai Wang
- Hepato-Biliary-Pancreatic Surgery Division, Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China
- Kang Wang
- Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China
- Xin Wang
- Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, China
- Wenjing Wei
- Department of General Surgery, Taiyuan People’s Hospital, Taiyuan, China
- Fei-Xiang Wu
- Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China
- Bangde Xiang
- Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China
- Lin Xie
- Department of Oncology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China
- Jianming Xu
- ORCiD
- Department of Gastrointestinal Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
- Mao-Lin Yan
- Department of Hepatobiliary and Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou, China
- Yufu Ye
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
- Jinbo Yue
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, First Medical University and Shandong Academy of Medical Sciences, Jinan, China
- Xiaoxun Zhang
- Department of Liver Surgery & Liver Transplantation Centre, West China Hospital of Sichuan University, Chengdu, China
- Yu Zhang
- Hepatobiliary and Pancreatic Surgery Department, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
- Aibin Zhang
- Department of Hepatobiliary Pancreatic Surgery, The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, China
- Haitao Zhao
- Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Weifeng Zhao
- Department of Infectious Diseases, The First Affiliated Hospital of Soochow University, Suzhou, China
- Xin Zheng
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
- Hongkun Zhou
- Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jiaxing, Affiliated Hospital of Jiaxing College, Jiaxing, China
- Huabang Zhou
- Department of Gastroenterology, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China
- Jun Zhou
- Department of Medical Oncology, Beijing Cancer Hospital, Beijing, China
- Xinmin Zhou
- Department of Gastroenterology, Xijing Hospital, Air Force Medical University, Xi'an, China
- Shu-Qun Cheng
- Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China
- Qiu Li
- Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China
Abstract
Background: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in China. Most HCC patients have the complications of chronic liver disease and need overall consideration and whole-course management, including diagnosis, treatment, and follow-up. To develop a reasonable, long-term, and complete management plan, multiple factors need to be considered, including the patient’s general condition, basic liver diseases, tumor stage, tumor biological characteristics, treatment requirements, and economic cost. Summary: To better guide the whole-course management of HCC patients, the Chinese Association of Liver Cancer and the Chinese Medical Doctor Association has gathered multidisciplinary experts and scholars in relevant fields to formulate the “Chinese Expert Consensus on The Whole-Course Management of Hepatocellular Carcinoma (2023).” Key Messages: This expert consensus, based on the current clinical evidence and experience, proposes surgical and nonsurgical HCC management pathways and involves 18 recommendations, including perioperative treatment, systematic treatment combined with local treatment, conversion treatment, special population management, symptomatic support treatment, and follow-up management.
Keywords
